Perwad, F., Portale, A. A., Carpenter, T. O., Briot, K., Imel, E. A., Kamenicky, P., . . . Insogna, K. L. (2020). OR29-01 Long-Term Safety in Adults with X-Linked Hypophosphatemia (XLH) Treated with Burosumab, a Fully Human Monoclonal Antibody Against FGF23: Final Results of a Phase 3 Trial. J Endocr Soc.
Citação norma ChicagoPerwad, Farzana, et al. "OR29-01 Long-Term Safety in Adults With X-Linked Hypophosphatemia (XLH) Treated With Burosumab, a Fully Human Monoclonal Antibody Against FGF23: Final Results of a Phase 3 Trial." J Endocr Soc 2020.
Citação norma MLAPerwad, Farzana, et al. "OR29-01 Long-Term Safety in Adults With X-Linked Hypophosphatemia (XLH) Treated With Burosumab, a Fully Human Monoclonal Antibody Against FGF23: Final Results of a Phase 3 Trial." J Endocr Soc 2020.